At this time, two of three conferences have been reverted to a in-person and virtual format. This includes The American Urological Association (AUA) 2021 Annual Meeting and the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting.
Interest and research into urothelial cancer is growing and with that, the number of medical conferences where urothelial cancer will be an important topic. The delta variant of the COVID-19 virus is wreaking havoc with conference planning. A number of groups have pulled back their plans for an in-person meeting and have gone back to a virtual format.
The AUA annual meeting will be held in-person and virtually September 10-13, 2021 from Las Vegas, Nevada, and the program will offer evidence-based medical information for urologists and other healthcare professionals in the field globally, which includes the latest research, new guidelines, and advances in the specialty. Here are some of the topics that will be presented at the conference:
This conference was postponed in 2020 and is now scheduled to take place October 16-21, 2021 in Aspen, Colorado. Physicians and other healthcare professionals from all disciplines who treat cancer patients generally attend this conference. The conference agenda will be available soon, and the focus will include diagnosis and management options that improve health outcomes.
The SITC conference is scheduled for November 10-14, 2021 at the Walter E. Washington Convention Center in Washington D.C. and will include virtual options. Additionally, this is the largest conference to focus solely on cancer immunotherapy that brings together international leaders from academia, regulatory and government agencies, and industry representatives. Conference agenda topics and events include the following: